Additionally, METTL3 promotes the suppressor of cytokine signaling 2 (SOCS2) degradation in gliomas by promoting an m6A methylation modification of SOCS2 to inhibit M1 macrophage polarization. This evidence concerns the gene SOCS2 and central nervous system cancer.